Duthoo E, Beyls E, Backers L, Gudjonsson T, Huang P, Jonckheere L
J Exp Med. 2025; 222(5).
PMID: 40029331
PMC: 11874998.
DOI: 10.1084/jem.20241432.
Lin S, Hsueh C, Chen W, Chou T, Wong R
Cancers (Basel). 2025; 17(3).
PMID: 39941729
PMC: 11816221.
DOI: 10.3390/cancers17030359.
Settayanon S, Chanvorachote P, Mutirangura A
Sci Rep. 2025; 15(1):3215.
PMID: 39863746
PMC: 11762752.
DOI: 10.1038/s41598-025-87773-3.
Hofer S, Frasch L, Brajkovic S, Putzker K, Lewis J, Schurmann H
Mol Syst Biol. 2025; 21(3):231-253.
PMID: 39838187
PMC: 11876601.
DOI: 10.1038/s44320-025-00085-6.
Awwad S, Doyle C, Coulthard J, Bader A, Gueorguieva N, Lam S
Nat Commun. 2025; 16(1):480.
PMID: 39779698
PMC: 11711288.
DOI: 10.1038/s41467-024-55637-5.
PARP inhibition radiosensitizes BRCA1 wildtype and mutated breast cancer to proton therapy.
Ben Kacem M, Bright S, Moran E, Flint D, Martinus D, Turner B
Sci Rep. 2024; 14(1):30897.
PMID: 39730675
PMC: 11680706.
DOI: 10.1038/s41598-024-81914-w.
Interaction of DDB1 with NBS1 in a DNA Damage Checkpoint Pathway.
Lim H, Lim H, Yoo H
Int J Mol Sci. 2024; 25(23).
PMID: 39684807
PMC: 11642328.
DOI: 10.3390/ijms252313097.
Exploring RPA1-ETAA1 axis via high-throughput data analysis: implications for PD-L1 nuclear translocation and tumor-immune dynamics in liver cancer.
Qin G, Chen Z, Tian W, Chen H, Zhang Y, Wei W
Front Immunol. 2024; 15:1492531.
PMID: 39660144
PMC: 11628550.
DOI: 10.3389/fimmu.2024.1492531.
Loss of Brcc3 in Zebrafish Embryos Increases Their Susceptibility to DNA Damage Stress.
Wang Z, Wang C, Zhai Y, Bai Y, Wang H, Rong X
Int J Mol Sci. 2024; 25(22).
PMID: 39596176
PMC: 11594080.
DOI: 10.3390/ijms252212108.
The herpes simplex virus alkaline nuclease is required to maintain replication fork progression.
Mullon P, Maldonado-Luevano E, Mehta K, Mohni K
J Virol. 2024; 98(12):e0183624.
PMID: 39508568
PMC: 11650972.
DOI: 10.1128/jvi.01836-24.
Targeting the DNA damage response in cancer.
Federica G, Michela C, Giovanna D
MedComm (2020). 2024; 5(11):e788.
PMID: 39492835
PMC: 11527828.
DOI: 10.1002/mco2.788.
BubR1 and SIRT2: Insights into aneuploidy, aging, and cancer.
Pun R, Kumari N, Monieb R, Wagh S, North B
Semin Cancer Biol. 2024; 106-107:201-216.
PMID: 39490401
PMC: 11625622.
DOI: 10.1016/j.semcancer.2024.10.005.
Opening and changing: mammalian SWI/SNF complexes in organ development and carcinogenesis.
Abu Sailik F, Emerald B, Ansari S
Open Biol. 2024; 14(10):240039.
PMID: 39471843
PMC: 11521604.
DOI: 10.1098/rsob.240039.
APE1 is a master regulator of the ATR-/ATM-mediated DNA damage response.
Zhao H, Richardson C, Marriott I, Yang I, Yan S
DNA Repair (Amst). 2024; 144():103776.
PMID: 39461278
PMC: 11611674.
DOI: 10.1016/j.dnarep.2024.103776.
The Influence of Circadian Rhythms on DNA Damage Repair in Skin Photoaging.
Su Z, Hu Q, Li X, Wang Z, Xie Y
Int J Mol Sci. 2024; 25(20).
PMID: 39456709
PMC: 11507642.
DOI: 10.3390/ijms252010926.
A TRilogy of ATR's Non-Canonical Roles Throughout the Cell Cycle and Its Relation to Cancer.
Joo Y, Ramirez C, Kabeche L
Cancers (Basel). 2024; 16(20).
PMID: 39456630
PMC: 11506335.
DOI: 10.3390/cancers16203536.
p53-dependent crosstalk between DNA replication integrity and redox metabolism mediated through a NRF2-PARP1 axis.
Elfar G, Aning O, Ngai T, Yeo P, Chan J, Sim S
Nucleic Acids Res. 2024; 52(20):12351-12377.
PMID: 39315696
PMC: 11551750.
DOI: 10.1093/nar/gkae811.
Factors Influencing the Central Nervous System (CNS) Distribution of the Ataxia Telangiectasia Mutated and Rad3-Related Inhibitor Elimusertib (BAY1895344): Implications for the Treatment of CNS Tumors.
Rathi S, Mladek A, Oh J, Dragojevic S, Burgenske D, Zhang W
J Pharmacol Exp Ther. 2024; 391(2):346-360.
PMID: 39284626
PMC: 11493447.
DOI: 10.1124/jpet.123.002002.
ATR inhibition radiosensitizes cells through augmented DNA damage and G2 cell cycle arrest abrogation.
Bright S, Manandhar M, Flint D, Kolachina R, Ben Kacem M, Martinus D
JCI Insight. 2024; 9(19).
PMID: 39235982
PMC: 11466186.
DOI: 10.1172/jci.insight.179599.
Combined strategies with PARP inhibitors for the treatment of BRCA wide type cancer.
Xie Y, Xiao D, Li D, Peng M, Peng W, Duan H
Front Oncol. 2024; 14:1441222.
PMID: 39156700
PMC: 11327142.
DOI: 10.3389/fonc.2024.1441222.